Skip to main content Skip to main navigation menu Skip to site footer

Efficacy Comparison of Mannitol and Hypertonic Saline for Traumatic Brain Injury (TBI) Treatment



Abstract

Traumatic Brain Injury (TBI) case is commonly found in the emergency room.  TBI accompanied by increased intracranial pressure (ICP) is a neurological emergency that requires prompt and appropriate management. Hyperosmolar fluid is the main treatment in the initial management of increased ICP. Mannitol and hypertonic saline are hyperosmolar fluids which are generally used. There is no specific recommendation regarding the choice between the two fluids. From the current studies indicate that both fluids are equally effective in reducing ICP. Regarding the superiority between the two fluids, it is difficult to determine because of the heterogeneity of the studies that exist. Therefore, clinicians should choose between hyperosmolar fluids based on indications and contraindications exist in TBI patients.

Keywords: Traumatic brain injury increased intracranial pressure comparison Mannitol hypertonic saline

References

  1. References
  2. Garvin R, Venkatasubramanian C, Lumba-Brown A, Miller CM. Emergency Neurological Life Support: Traumatic Brain Injury. Neurocritical care. 2015;23 Suppl 2:S143-54.
  3. Tim Neurotrauma RSUD Dr. Soetomo-Fakultas Kedokteran Universitas Airlangga. Pedoman Tatalaksana Cedera Otak. Second ed. Surabaya: Revka Petra Media; 2014.
  4. Zamzami NM, Fuadi I, Nawawi AM. Angka Kejadian dan Outcome Cedera Otak di RS. Hasan Sadikin Bandung Tahun 2008-2010. Jurnal Neuroanastesi Indonesia. 2013;2(2):89-94.
  5. Steiner LA, Andrews PJ. Monitoring the injured brain: ICP and CBF. British journal of anaesthesia. 2006;97(1):26-38.
  6. Sadoughi A, Rybinnik I, Cohen R. Measurement and management of increased intracranial pressure. Open Crit Care Med J. 2013;6(1):56-65.
  7. American College of Surgeons Committee on Trauma. Advanced Trauma Life Support Student Course Manual. Ninth ed. USA: American College of Surgeons; 2012.
  8. Shawkat H, Westwood M-M, Mortimer A. Mannitol: a review of its clinical uses. Continuing Education in Anaesthesia, Critical Care & Pain. 2012;12(2):82-5.
  9. Brophy GM, Human T, Shutter L. Emergency Neurological Life Support: Pharmacotherapy. Neurocritical care. 2015;23 Suppl 2:S48-68.
  10. Nissenson AR, Weston RE, Kleeman CR. Mannitol. Western Journal of Medicine. 1979;131(4):277-84.
  11. Surani S, Lockwood G, Macias MY, Guntupalli B, Varon J. Hypertonic saline in elevated intracranial pressure: past, present, and future. Journal of intensive care medicine. 2015;30(1):8-12.
  12. Feig PU, McCurdy DK. The Hypertonic State. New England Journal of Medicine. 1977;297(26):1444-54.
  13. Doyle JA, Davis DP, Hoyt DB. The use of hypertonic saline in the treatment of traumatic brain injury. The Journal of trauma. 2001;50(2):367-83.
  14. Hartl R, Medary MB, Ruge M, Arfors KE, Ghahremani F, Ghajar J. Hypertonic/hyperoncotic saline attenuates microcirculatory disturbances after traumatic brain injury. The Journal of trauma. 1997;42(5 Suppl):S41-7.
  15. Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Critical care medicine. 2000;28(9):3301-13.
  16. Vialet R, Albanese J, Thomachot L, Antonini F, Bourgouin A, Alliez B, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Critical care medicine. 2003;31(6):1683-7.
  17. Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Critical care medicine. 2005;33(1):196-202; discussion 57-8.
  18. Oddo M, Levine JM, Frangos S, Carrera E, Maloney-Wilensky E, Pascual JL, et al. Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. Journal of neurology, neurosurgery, and psychiatry. 2009;80(8):916-20.
  19. Cottenceau V, Masson F, Mahamid E, Petit L, Shik V, Sztark F, et al. Comparison of effects of equiosmolar doses of mannitol and hypertonic saline on cerebral blood flow and metabolism in traumatic brain injury. Journal of neurotrauma. 2011;28(10):2003-12.
  20. Sakellaridis N, Pavlou E, Karatzas S, Chroni D, Vlachos K, Chatzopoulos K, et al. Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries. Journal of neurosurgery. 2011;114(2):545-8.
  21. Mangat HS, Chiu YL, Gerber LM, Alimi M, Ghajar J, Hartl R. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury. Journal of neurosurgery. 2015;122(1):202-10.
  22. Burgess S, Abu-Laban RB, Slavik RS, Vu EN, Zed PJ. A Systematic Review of Randomized Controlled Trials Comparing Hypertonic Sodium Solutions and Mannitol for Traumatic Brain Injury: Implications for Emergency Department Management. The Annals of pharmacotherapy. 2016;50(4):291-300.
  23. Boone MD, Oren-Grinberg A, Robinson TM, Chen CC, Kasper EM. Mannitol or hypertonic saline in the setting of traumatic brain injury: What have we learned? Surgical neurology international. 2015;6:177.

How to Cite

Arifianto, M. R., Ma’ruf, A. Z., & Ibrahim, A. (2016). Efficacy Comparison of Mannitol and Hypertonic Saline for Traumatic Brain Injury (TBI) Treatment. Bali Medical Journal, 5(3), 516–521. https://doi.org/10.15562/bmj.v5i3.281
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
3

Total
21

Share

Search Panel

Muhammad Reza Arifianto
Google Scholar
Pubmed
BMJ Journal

Achmad Zuhro Ma'ruf
Google Scholar
Pubmed
BMJ Journal

Arie Ibrahim
Google Scholar
Pubmed
BMJ Journal